Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ethanol, commonly known as alcohol, is a clear, colorless, and volatile liquid that serves as the primary psychoactive ingredient in alcoholic beverages and is widely utilized as a solvent and antiseptic. Pharmacologically, it is a potent central nervous system (CNS) depressant that exerts its effects by modulating several neurotransmitter systems, most notably through the potentiation of inhibitory GABA-A receptors and the antagonism of excitatory NMDA receptors. Acute intake leads to sedation, impaired coordination, and euphoria, whereas chronic exposure induces neuroadaptive changes that underlie tolerance, physical dependence, and alcohol use disorder. Beyond its neurological impact, ethanol is metabolized by enzymes such as alcohol dehydrogenase into acetaldehyde, a toxic and carcinogenic intermediate that contributes to multi-organ damage, including alcoholic liver disease and various cancers. Therapeutic strategies for managing its effects focus on interfering with its metabolic pathway or modulating the brain's reward circuitry to reduce craving and withdrawal.
Ethanol acts primarily as a positive allosteric modulator of the GABA-A receptor, which enhances inhibitory signaling, and as an antagonist of NMDA glutamate receptors, which suppresses excitatory neurotransmission. It also triggers the release of dopamine and endogenous opioids in the mesolimbic reward pathway, particularly within the nucleus accumbens, reinforcing its addictive potential. Additionally, ethanol interacts with various other proteins including serotonin receptors, nicotinic acetylcholine receptors, and metabolic enzymes such as alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ethanol (Ethyl alcohol) (EtOH).